in order to test different polyclonal antibody regimes as early prophylaxis against cardiac rejection , 42 patients ( ages 30 to 60 years ) transplanted at the university of michigan from december 1986 to august 1988 were randomized to receive antithymocyte globulin ( atgam , upjohn , n = 19 ) or antilymphoblast globulin ( malg , university of minnesota , n = 23 ) .
C0003442
antithymocyte globulin
C0004149
atgam